XML 28 R16.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS’ EQUITY (DEFICIT)
9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
STOCKHOLDERS’ EQUITY (DEFICIT) STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred Stock

The Company has authorized the issuance of 10,000,000 shares of undesignated preferred stock with a par value of $0.0001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of September 30, 2021, there were no issued and outstanding shares of preferred stock.

Common Stock
On July 23, 2021, in connection with the reverse recapitalization treatment of the Merger, the Company effectively issued 425,395,023 new shares of common stock upon the Closing. The Company also converted all 1,155,909,367 shares of its issued and outstanding convertible preferred stock into 1,155,909,367 new shares of common stock as of the Closing of the Merger based upon the conversion rate as calculated pursuant to Legacy Lucid’s memorandum and articles of association. Immediately following the Merger, there were 1,618,621,534 shares of common stock outstanding with a par value of $0.0001. The holder of each share of common stock is entitled to one vote.
Common Stock Warrants

On July 23, 2021, in connection with the reverse recapitalization treatment of the Merger, the Company effectively issued 41,400,000 publicly-traded warrants to purchase shares of its common stock. Each whole warrant entitles the holder to purchase one share of the Company’s common stock at a price of $11.50 per share. The public warrants were exercisable as of August 22, 2021 and expire on July 23, 2026, if not yet exercised by the holder or redeemed by the Company.

During the three and nine months ended September 30, 2021, an aggregate of 32,082,532 public warrants were exercised, of which 17,015,311 were exercised on a cashless basis. The aggregate cash proceeds received from the exercise of these public warrants were $173.3 million. A summary of activity of the Company’s issued and outstanding public warrants is as follows:
September 30,
2021
Public warrants issued in connection with Merger on July 23, 202141,400,000 
Number of public warrants exercised(32,082,532)
Issued and outstanding public warrants as of September 30, 20219,317,468 

On September 8, 2021 the Company issued a redemption notice to the holders of the public warrants pursuant to which the Company would redeem any remaining issued and outstanding warrants at a price of $0.01 per warrant at the scheduled redemption date. Upon the redemption notification, holders of the public warrants only had the right to exercise their outstanding warrants prior to the scheduled redemption date on a cashless basis. On October 14, 2021, the Company extended the redemption date to October 29, 2021. Subsequent to September 30, 2021 and prior to the conclusion of the redemption notice period on October 29, 2021, an aggregate of 8,951,665 public warrants were exercised on a cashless basis. At the conclusion of the redemption notice period on October 29, 2021, the remaining 365,803 public warrants issued and outstanding were redeemed at price of $0.01 per warrant.
Common Stock Reserved for Issuance
The Company’s common stock reserved for future issuances as of September 30, 2021 and December 31, 2020, are as follows:
September 30,
2021
December 31,
2020
Convertible preferred stock (on an as-converted basis)— 957,159,704 
Convertible preferred stock warrant (on an as-converted basis)— 1,546,799 
Private warrants to purchase common stock44,350,000 — 
Public warrants to purchase common stock9,317,468 — 
Stock options outstanding67,013,622 70,675,318 
Restricted stock units outstanding43,183,277 — 
Shares available for future grants under equity plans12,894,374 10,526,235 
Total shares of common stock reserved176,758,741 1,039,908,056